This HTML5 document contains 140 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1093/NAR/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36098377
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 1986) vetenskaplig artikel научна статия teaduslik artikkel scienca artikolo мақолаи илмӣ artigo científico (publicado na 1986) 1986年論文 articol științific 1986年论文 naučni članak vitskapeleg artikkel vedecký článok bài báo khoa học מאמר מדעי مقالة علمية نشرت في مايو 1986 article scientific บทความทางวิทยาศาสตร์ mokslinis straipsnis мақолаи илмӣ 1986年论文 artículu científicu espublizáu en 1986 գիտական հոդված ১৯৮৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikulong pang-agham videnskabelig artikel (udgivet 1986) 1986年論文 articolo scientifico სამეცნიერო სტატია 1986年論文 наукова стаття, опублікована в травні 1986 vitenskapelig artikkel article científic научни чланак επιστημονικό άρθρο مقالهٔ علمی 1986年論文 tieteellinen artikkeli artykuł naukowy 1986年论文 wetenschappelijk artikel vědecký článek 1986年论文 научная статья artikull shkencor tudományos cikk 1986 nî lūn-bûn 1986年论文 1986年論文 bilimsel makale article scientifique (publié 1986) artigo científico سائنسی مضمون scientific article 1986年の論文 artículo científico publicado en 1986 1986년 논문 научни чланак wissenschaftlicher Artikel 1986年论文
p:P577
wds:Q36098377-51A56667-F365-4B91-92ED-DFE8C4EA0238
wdt:P577
1986-05-01T00:00:00Z
p:P407
wds:Q36098377-C54497D9-F9BB-4C5D-8287-B4AA8D4FAFD7
wdt:P407
wd:Q1860
p:P2860
wds:Q36098377-02B284EE-5CBB-4027-9CAF-787B3FE3BA82 wds:Q36098377-07804B75-B71A-4230-BE52-C7EBBB638019 wds:Q36098377-12FE98AB-1AE7-490F-809A-305A36EA3339 wds:Q36098377-188A30D7-6258-4CAE-A8DA-D071EBC88737 wds:Q36098377-1DAEC58F-8AE5-4130-BAA5-B6CE3EC5A938 wds:Q36098377-44AC05E7-58DE-45D8-859C-66CE4A16433F wds:Q36098377-5463D22D-B718-4FCB-B4E3-D694D1CAB07C wds:Q36098377-718CCBA7-5145-4E55-A64A-7177B848466A wds:Q36098377-8DB5589D-EBB8-45D5-B857-B706661E5D0C wds:Q36098377-9E2ECB7C-610A-4E02-8280-2EC12DA6CCD8 wds:Q36098377-B185785B-0407-44BA-A4FE-5C62E80470EE wds:Q36098377-CD57A46E-F206-430A-998A-C455EE7B90EC wds:Q36098377-E9AE9B1C-BC44-45F7-8106-E02522803656 wds:Q36098377-F38E2F8A-C9BC-437C-92EE-51191CDDAA02 wds:Q36098377-F64A5B88-6044-4A00-B3F4-4157BBE612E9 wds:Q36098377-F81A8F87-0663-4079-A16C-BADE04777FC6 wds:Q36098377-F8F38F6B-67FD-4AB2-9C3C-AA01AE7F0632
wdt:P2860
wd:Q67391512 wd:Q37596172 wd:Q37344033 wd:Q72405319 wd:Q36133723 wd:Q35042255 wd:Q72732710 wd:Q36135179 wd:Q29616239 wd:Q40499388 wd:Q35994466 wd:Q35083833 wd:Q34238119 wd:Q70212180 wd:Q52457368 wd:Q40306264 wd:Q66909735
p:P2093
wds:Q36098377-AB3D7404-AA54-4E7C-B003-361045643651 wds:Q36098377-F04DF07D-78BB-49AC-83A4-DC6A1EA58552 wds:Q36098377-419A9FC6-B711-4CF3-B426-0965EAE18772 wds:Q36098377-4E770768-AE95-4190-A72F-C7775A51E40D
wdt:P2093
R Chalkley L Sealy D Bresnahan S Thompson
rdfs:label
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase
skos:prefLabel
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase
schema:name
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase
p:P50
wds:Q36098377-F384328F-5C5D-4144-B28E-907667E3846A
wdt:P50
wd:Q29397456
p:P1476
wds:Q36098377-D03ED724-5122-4D20-8BAC-4E372166C3C6
wdt:P1476
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase
p:P304
wds:Q36098377-A19C49CF-4644-4FD9-954F-147D7CD73792
wdt:P304
3671-3686
p:P31
wds:Q36098377-87FA4BEB-0AFE-4A72-B028-C162A40B9887
wdt:P31
wd:Q13442814
p:P698
wds:Q36098377-57146562-F34F-4720-9A2D-4B4E4CD55B8D
wdtn:P698
n8:3714493
wdt:P698
3714493
p:P1433
wds:Q36098377-E1B102FE-9EC6-4D6C-BB2E-9400D0B6993B
wdt:P1433
wd:Q135122
p:P433
wds:Q36098377-5A07A329-E78B-4D0F-8E36-D4D5566CC74B
p:P478
wds:Q36098377-E7447997-84B8-4C8E-9090-7D6B3B936CDF
wdt:P433
9
wdt:P478
14
p:P356
wds:Q36098377-63EEDAA6-ED71-4E45-B5EC-BF9613C6B88F
wdtn:P356
n12:14.9.3671
wdt:P356
10.1093/NAR/14.9.3671
p:P5875
wds:Q36098377-EA5657D9-3D1C-4CDD-92DF-A9DDD6EC9D68
wdt:P5875
19446429
p:P932
wds:Q36098377-DE4E34A5-10E5-4ECF-8EEB-E74976CC98B8
wdt:P932
339807